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Abstract
The cell adhesion molecule Close Homologue of L1 (CHL1) is important for apical dendritic
projection and laminar positioning of pyramidal neurons in caudal regions of the cerebral cortex.
The p21-activated kinase (PAK 1-3) subfamily of serine/threonine kinases has also been implicated
in regulating cell adhesion, migration, and morphology. Immunofluorescence staining in mouse
embryonic brain showed that PAK1-3 was expressed in embryonic cortex and colocalized with CHL1
during neuronal migration and differentiation. To investigate a cooperative function for CHL1 and
PAK in pyramidal cell differentiation or migration, a dominant-negative PAK mutant (PAK1 AID)
that inhibits PAK1-3 kinase activity while coexpressing a green fluorescent protein (GFP) reporter
was electroporated into the lateral ventricles of wild type and CHL1 null mutant mouse embryos
(E14.5), then brain slices were cultured and neurons analyzed for laminar positioning and
morphology by confocal microscopy after 3 days in vitro. Expression of PAK1 AID in CHL1 mutant
cortex inactivated PAK and caused embryonic cortical neurons to branch profusely in the
intermediate zone and cortical plate. The number of nodes, terminals and length of leading processes/
apical dendrites of CHL1 mutant embryos expressing PAK1 AID increased dramatically, compared
to CHL1 mutants without PAK1 AID, or wild type embryos with or without PAK1 AID. These
findings suggest that CHL1 and PAK1-3 kinase cooperate, most likely in independent pathways, in
regulating morphological development of the leading process/apical dendrite of embryonic cortical
neurons.
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The neural cell recognition molecule Close Homolog of L1 (CHL1) is a member of the L1
family of neural cell adhesion molecules, which includes L1, CHL1, NrCAM, and Neurofascin
{Maness, 2007 #3564}. CHL1 is required for laminar positioning and dendritic projection of
pyramidal neurons in the posterior region of the developing mouse neocortex, where CHL1 is
expressed in a high-caudal to low-rostral gradient (Demyanenko et al., 2004). Deep layer
pyramidal neurons of CHL1-minus mice are malpositioned to lower laminar positions in the
visual and somatosensory cortex, and develop misoriented, often inverted, apical dendrites
(Demyanenko et al., 2004). Although CHL1 potentiates cell migration through β1 integrins,
Src and ERK MAP kinase in culture (Buhusi et al., 2003, Demyanenko et al., 2004), the
molecular mechanism by which CHL1 regulates neuronal process outgrowth and positioning
in the developing neocortex is unclear.
The p-21-activated kinases (PAK) are potential signaling effectors in cortical neurons, as they
interact with many of the molecular components involved in migration, process outgrowth,
and spine morphogenesis (Nikolic, 2008). PAKs comprise a family of serine-threonine kinases
consisting of Group I PAK1-3, which share extensive homology and phosphorylation sites,
and Group II PAK 4-6, which vary from the canonical structure (Jaffer and Chernoff, 2002).
Phosphorylation of PAK1 at Thr423, and equivalent sites in PAK2,3, is necessary for
stabilization of the active kinase conformation (Zenke et al., 1999, Lei et al., 2000), however
kinase-dependent and kinase-independent functions of PAK have been identified (Bokoch,
2003, Zhang et al., 2005, Higuchi et al., 2008). PAK1-3 are downstream effectors of the Rho
GTPases Rac1 and Cdc42, which play a major role in cell motility, process outgrowth, and
dendrite and axon guidance (Nikolic et al., 1998, Edwards et al., 1999, Rashid et al., 2001,
Bokoch, 2003, Nikolic, 2008). Loss of PAK1 function disrupts the morphology of migrating
neurons, which accumulate in the IZ and deep cortical layers (Causeret et al., 2009).
We speculated that PAK1-3 may function coordinately with CHL1 as an important determinant
of cortical pyramidal neuron differentiation. PAK kinase activity has been implicated in
controlling premature neuronal differentiation and promoting migration (Hayashi et al.,
2002, Sakakibara and Horwitz, 2006, Cobos et al., 2007, Hayashi et al., 2007). Moreover,
PAK1 is involved in L1- and integrin-dependent haptotactic cell migration in vitro (Schmid et
al., 2004, Schmid and Maness, 2008). To investigate a coordinate function for PAK and CHL1
in morphological differentiation and positioning of embryonic cortical pyramidal neurons, we
examined PAK 1-3 and CHL1 expression in the developing mouse neocortex, and analyzed
the effects of electroporation-mediated gene transfer of a dominant negative PAK1
autoinhibitory domain (AID) mutant on neurons in CHL1 null mutant and wild type mice. We
show here that combined loss of CHL1 and inhibition of PAK1-3 kinase induced abnormal
branching of developing cortical neurons, thus providing evidence that CHL1 cooperates with
PAK 1-3, most likely in independent pathways, to regulate morphology of embryonic cortical
neurons important for normal neuronal development.
Experimental Procedures
Mice
Generation and propagation of mice in which the CHL1 gene was knocked out by homologous
recombination was described previously (Montag-Sallaz et al., 2002, Demyanenko et al.,
2004). CHL1 homozygous null and wild type controls were on a C57Bl/6 genetic background.
All experiments were approved by the animal care committee of The University of North
Carolina at Chapel Hill, USA (in accordance with the National Institute of Health Guide for
the Care and Use of Laboratory Animals (NIH Publications No. 80-23 revised 1996).
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Affinity-purified rabbit polyclonal antibodies raised against a 19-residue peptide mapping at
the carboxyl terminus of PAK1, which cross reacts with PAK2 and PAK3 (Santa Cruz
Biotechnology, Inc.: sc-881), was used for detection of PAK1-3. This antibody was previously
characterized in neuronal cultures (Rashid et al., 2001). Antibody 2601 to active PAK1-3
isoforms phosphorylated at Thr423, Thr402, or Thr421, respectively, was from Cell Signaling
Technology, Inc. (Danvers, MA). CHL1/L1CAM2/CALL antibody (R&D systems: AF2147)
was used for detection of CHL1. Specificity of this antibody against CHL1 was confirmed
previously by us and others (Demyanenko et al., 2004, Nikonenko et al., 2006, Wright et al.,
2007). These antibodies do not cross-react with other L1 family members in embryonic mouse
brain or transfected HEK293 cells, and show no nonspecific immunostaining of homozygous
CHL1-minus brain (Nikonenko et al., 2006). Rabbit polyclonal anti-green fluorescent protein
(GFP) antibody (Invitrogen: A11122) was used to enhance GFP detection in neurons
electroporated with pCIG2 plasmids. RC2 antibody was obtained from the Developmental
Hybridoma Bank (University of Iowa).
Timed pregnant mice were deeply anesthetized with avertin (2.5% 0.02 mL/g in saline,
intraperitoneally), and embryos were removed and immersion fixed in 4% paraformaldehyde
overnight. Sections were cut on a vibratome at 60 µm, fixed in ice-cold methanol (10 min),
washed with PBS, and permeabilized with blocking solution: 0.2% Triton X-100, 0.5% fish
skin gelatin, and 10% donkey serum for 1 hr at room temperature. Sections were stained
overnight with anti-PAK1-3 (1:250) and/or anti-CHL1 (1:100) antibodies in blocking solution/
PBS (1:1). Sections were washed and incubated with FITC or TRITC- conjugated secondary
antibodies (Jackson ImmunoResearch Laboratories, Inc) for 1 hr in a light protected chamber.
Sections were washed and embedded in Vectashield (Vector Labs) and visualized by confocal
microscopy. Immunofluorescent staining was performed on 4 embryos of each genotype.
Plasmids
Amino acids 83–149 of hPAK1 cDNA, comprising the auto-inhibitory domain (AID) of PAK
1 (Zhao et al., 1998) were amplified by PCR from plasmid pCMV6-myc-PAK1(83–149)(Sells
et al., 1997) (gift of Tina Leisner, UNC Chapel Hill) and inserted into pCIG2 (Hand et al.,
2005) (gift of Dante Bortone, UNC Chapel Hill) at XhoI and XmaI to make the pCIG2 PAK1
AID plasmid, which expresses the AID domain under the chicken β-actin promoter with a
CMV early-immediate enhancer. EGFP is expressed from an internal IRES sequence in the
same plasmid containing PAK1 AID, ensuring coexpression. Inserts were verified by DNA
sequencing.
Electroporation
Ex vivo electroporation (Swartz et al., 2001) was performed as described (Hand et al., 2005).
Embryos at E14.5 were removed and placed in ice-cold HBSS from deeply anesthetized
(Avertin 2.5%, 0.02 ml/gm) time-pregnant CHL1 mutant and wild type mice. A solution
containing DNA, either pCIG2 or pCIG2 PAK AID at 2 µg/µL in PBS (pH 7.3) with Fast green
(0.01%) as tracer (Sigma) was injected into the lateral ventricles of each hemisphere of embryos
using glass micropipettes for 5 – 10 pulses at 3–4 msec/pulse 55V (100 msec duration with
500 msec intervals between each pulse) using a ECM 830 electroporator (BTX Harvard
Apparatus) and 7 mm stainless steel tweezers electrodes (Harvard Apparatus, Holliston, MA).
The positive electrode was situated over the dorsal lateral ventricle while the negative electrode
was situated along the neck on the contralateral side, causing selective uptake of the plasmid
DNA into the cells lining the lateral ventricles. Brains were dissected out and mounted in 3%
low-melting point agarose in complete HBSS, then sectioned at 300 µm on a Vibratome. Slices
were mounted on organotypic slice culture membranes previously coated with poly-L-lysine
(0.1 mg/mL) and laminin (0.01 mg/mL), then incubated in 35 mm dishes containing 1.2 mL
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slice culture medium (Polleux and Ghosh, 2002) in 5% CO2 at 37°C. Sections were incubated
for 2–4 days in culture. Following incubation, sections were fixed in 4% PFA in PBS (pH 7.4).
Fixed sections were washed in PBS, blocked in 10% goat serum, 3% BSA, and 0.3% Triton
X-100 for 1 hr at room temperature, then incubated with GFP antibody (1:1000) in blocking
solution at 4°C overnight, washed in PBS, and incubated with secondary antibody (Invitrogen
Corporation: A11008, 1:400) in blocking solution for 1 hr at room temperature. Than sections
were washed in PBS, mounted in Vectashield, and analyzed using confocal Zeiss 510
microscope. Phospho-PAK1 activity was analyzed in IRES-EGFP positive cells after 3 days
in culture. Sections (300 µm) were fixed in 4% PFA in PBS (pH=7.4) for 2 hours. Fixed sections
were washed in PBS, blocked in 10% goat serum, 3% BSA, 3% Triton X-100 overnight at 4°
C, then incubated with phospho-PAK1 (Thr423)/PAK2 (Thr402) antibody (1:250) in blocking
solution at 4°C. After 48 hours sections were washed in PBS and incubated with secondary
Alexa Fluor 546 antibody (Invitrogen, A11010, 1:400) in blocking solution overnight at 4°C.
Sections were again washed in PBS, mounted in Vectashield, and analyzed by confocal
microscopy.
Imaging and Neurolucida analysis
Confocal images were captured on a Zeiss LSM 510 (Confocal/Multiphoton Microscopy Core
Facility, Neuroscience Center, UNC Chapel Hill) or on a LSM5 Pascal Confocal Laser
Scanning Microscope (Microscopy Services Laboratory, Department of Pathology UNC
Chapel Hill). Confocal Z-stacks (from 20 images) were captured using 20x objective.
Projection images were calibrated for Neurolucida, fully integrated software for performing
anatomical mapping and neuron tracing. To quantify the number of nodes, ends and total length
of cell processes, the Auto Neuron tracing function of Neurolucida was used. Corresponding
means from experimental and control plasmid electroporations were compared by Student's t-
test for significant differences (p<0.05). Parametric one-way analysis of variance was used to
confirm mean differences in measurements across mouse plasmid groups with Tukey
adjustment of p-values for multiple comparisons. Statistical analysis was performed with SAS
statistical software, version 9.2 (SAS Institute Inc., Cary, NC).
For analysis of neuronal positioning, EGFP-positive cells were scored in a region of the
neocortex that extended 500 µm medially from the neocortex/archicortex boundary.
Maximum-brightness projections were made of each confocal Z-stack image using ImageJ
software (NIH). The boundaries of the ventricular and pial surfaces were marked manually and
the centers of the soma of EGFP-expressing cells were marked automatically. Automatic
marking was done by applying a band pass filter, thresholding, applying a watershed filter, and
using the Analyze Particles feature in ImageJ. Bins corresponding to the cortical plate and
marginal, intermediate, subventricular, and ventricular zones were identified from DAPI
staining, and the position of EGFP-positive cells was determined as described (Hand et al.,
2005). Corresponding bins from experimental and control plasmid electroporations were
compared by Student's t-test (p<0.05). Statistical assistance was obtained from Dr. Robert
Hamer (Department of Biostatistics School of Public Health, UNC at Chapel Hill and
biostatistician Wing K. Chiu (UNC Lineberger Comprehensive Cancer Center).
Results
PAK 1-3 expression in the developing cerebral cortex
To evaluate the importance of PAK in the developing cerebral cortex, the expression of Group
I PAK1-3 was examined by immunofluorescent staining in the developing neocortex of
embryonic and postnatal mice (Fig. 1A – E) using polyclonal antibody PAK1(C-19), which
also recognizes PAK 2 and 3. Cortical neurons undergo radial migration in the mouse neocortex
from approximately E14–E16, differentiate as they reach their appropriate laminar positions,
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and continue maturation during early postnatal stages (Nadarajah et al., 2002). In wild type
cortex at E14.5 high levels of PAK1-3 immunoreactivity were evident in the cortical plate (CP)
and intermediate zone (IZ), containing neurons migrating by somal translocation and glial-
guided mechanisms (Fig. 1A). Comparatively lower levels of PAK1-3 were seen in the
ventricular (VZ) and subventricular (SVZ) zones, containing proliferating progenitors (Fig.
1A). In wild type cortex at E15.5 PAK1-3 expression occurred throughout the cortex, and was
especially high in axonal fibers in the IZ (Fig. 1B). We scored the number of cells that were
PAK1-3 immunopositive in different cortical layers of wild type E15.5 cortex counterstained
with DAPI (not shown) in single confocal images. All DAPI-stained cells were PAK1-3
immunopositive in the CP/MZ (n=173), the IZ (n=193), and in VZ (n-183), thus PAK1-3 did
not appear to be restricted to a particular layer or cell type. In homozygous CHL1 null mutants,
the expression pattern of PAK1-3 in the neocortex was similar to wild type, as shown at E15.5
(Fig. 1C). PAK1-3 expression persisted in wild type embryos at E17.5, where it was strong in
the IZ but reduced in the VZ and CP (Fig. 1D). In wild type postnatal cortex (P12) PAK1-3
cells in all layers of the CP (II–VI) with highest level of expression in pyramidal cell soma and
processes in layers III and V, and somewhat lower levels in layer VI (Fig. 1E, boxes). Similar
results were obtained in CHL1 null mutants (not shown). Control staining with non-immune
IgG was negative at all stages (Fig. 1F). An antibody recognizing the activated forms of
PAK1-3, phosphorylated at threonine 423 in PAK1 or equivalent sites in PAK2-3, was used
to localize active PAK1-3 in wild type and CHL1 null embryonic cortex (E15.5) (Fig. 1G, H).
Active phospho-PAK1-3 was most prominent in fibers and cells in the IZ, with less staining
in the CP and VZ. The minimal differences in localization or intensity of phospho-PAK
immunoreactivity in wild type versus CHL1-minus cortex suggested that PAK1-3 may not be
a direct downstream effector of CHL1.
Immunoblotting was used to demonstrate that the PAK1(C-19) antibody was specific for
PAK1-3 in embryonic and postnatal cortex (Fig. 1I). PAK1 (upper band) was prominently
expressed in cortex from E14.5 to E17.5, as well as at postnatal and adult stages. Postnatal
expression of PAK1 is consistent with its known function in memory in the adult brain (Hayashi
et al., 2004,Zhang et al., 2005). PAK2,3 isoforms were also expressed at embryonic through
adult stages. The identification of PAK1-3 isoforms on Western blots was based on established
band patterns (Hayashi et al., 2002);(Hayashi et al., 2004). However, four newly recognized
splice variants of PAK 3 have been identified in adult mouse brain (Kreis et al., 2008), rendering
assignment tentative in the adult. In addition PAK1-3 may be modified by phosphorylation,
which can alter electrophoretic mobility. The developmental expression pattern of PAK
isoforms which we observed was in general accord with studies (Hayashi et al., 2002,Zhong
et al., 2003,Causeret et al., 2009) that used different PAK antibodies.
Double immunostaining for CHL1 and PAK1-3 in wild type embryos at E15.5 showed
colocalization of CHL1 and PAK1-3 in soma and processes of cells in the caudal neocortex,
where CHL1 is known to be abundant (Fig. 1J). Highest levels of CHL1 expression were seen
in the IZ, with lower levels in the CP, SVZ, and VZ, in agreement with our published study
(Demyanenko et al., 2004). Cells were scored for CHL1 immunoreactivity in the IZ/CP and
VZ/SVZ from single confocal images. All cells in the IZ/CP (111/111) and 3% of cells in the
VZ /SVZ (9/261) were immunopositive for CHL1. Furthermore, all of the CHL1-labeled cells
in the IZ and SVZ were found to also express PAK1-3, as shown by double labeling (Fig. 1J,
merge).
PAK1-3 and CHL1 cooperate to regulate morphology of embryonic cortical neurons
PAK1 contains a p21-binding domain (PBD) for Cdc42 and Rac1, an auto-inhibitory domain
(AID), and a serine/threonine-specific kinase domain, as well as sites for inhibitory Thr212
phosphorylation and Thr423 autophosphorylation (Fig. 2A). PAK controls a variety of cellular
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responses including motility by both kinase-dependent and kinase-independent functions
(Frost et al., 1998). Kinase-dependent functions of PAK1-3 can be inhibited by expression of
the auto-inhibitory domain (AID) of PAK1, comprising amino acids 83–149, which acts in a
dominant negative mechanism to inhibit the catalytic activity of PAK 1-3 isoforms (Zhao et
al., 1998). To study a potential role of PAK1-3 kinase in morphological differentiation or
neuronal positioning in the developing neocortex, PAK kinase was acutely suppressed by
electroporation-mediated expression of the dominant negative PAK1 AID from the plasmid
pCIG2 PAK AID, which co-expresses PAK1 AID and enhanced green fluorescent protein
(EGFP) polycistronically from an internal ribosome entry site (IRES) (Fig. 2B). Embryos
(E14.5) from timed pregnant wild type and CHL1 null mutant mice were removed from the
uterus and electroporated into the lateral ventricles with pCIG2 (control) or pCIG2 PAK AID
plasmids (2µg/µl). Slices were prepared from the caudal part of the cortex and maintained in
organotypic culture for 2–4 days in vitro. The pCIG2 plasmid provided strong expression of
EGFP allowing detection of cells in the VZ, IZ, CP and marginal zone (MZ) by 2–4 div.
After 3 div, electroporation of either pCIG2 or pCIG2 PAK1 AID plasmids into wild type
embryonic brains (E14.5) resulted in EGFP-positive cells in all layers of the developing
neocortex with maximal levels in the VZ and IZ (Fig. 2 C, E). Neurons labeled at E14.5 include
later migrating progenitors of pyramidal cells destined for layers II–IV (Anton et al., 1999).
To evaluate an effect on neuronal positioning, the percent of EGFP-positive cells was
quantified in each of 3 bins (VZ/SVZ, IZ, and CP/MZ) and analyzed for significant mean
differences (Fig. 3 A–C). Results showed that expression of PAK1 AID in wild type neurons
tended to decrease the percent of labeled neurons in the CP/MZ with a corresponding increase
in the VZ/SVZ, but these differences were not statistically significant at 3 div (Fig. 3 A–C) or
4 div (not shown). In contrast, expression of PAK1 AID in CHL1-deficient neurons resulted
in a statistically significant decrease in the percent of labeled neurons in the CP/MZ (Fig. 3 A–
C) as evaluated by either the t-test or 1-way ANOVA. Expression of pCIG2-PAK1 AID did
not further affect neuronal positioning in any of the cortical layers in either CHL1-minus or
wild type caudal cortex compared to the respective genotypes expressing pCIG2 (Fig. 3 A–C).
Most wild type neurons in the upper IZ and CP expressing pCIG2 showed one unbranched
leading process that was directed perpendicularly to the pial surface and often reached the MZ
(Fig. 2 D, arrows). Expression of pCIG2-PAK1 AID in wild type neurons affected their
morphology, causing some misorientation and branching of leading processes (Fig. 2 F,
arrows). Cells were scored from multiple confocal images for misoriented leading processes
or the presence of more than one branch from the leading process. Approximately 57% of wild
type neurons expressing pCIG2-PAK1AID (n=47 total) showed process misorientation with
respect to the pial surface or displayed multiple branches, compared to only 4.6% of wild type
cells expressing the control pCIG2 (n=108 total).
Most CHL1-minus neurons expressing pCIG2 or pCIG2-PAK1 AID were located in the VZ
and IZ, with some neurons present in the CP and MZ (Fig. 2 G,J). In agreement with our
previous findings (Demyanenko et al., 2004), pCIG2-expressing CHL1-minus neurons (Fig.
2G) showed a somewhat lower laminar positioning compared to pCIG2-expressing wild type
neurons (Fig. 2C). Quantification of pCIG2-expressing neurons showed a significantly
decreased percent of CHL1-minus neurons in the MZ/CP compared to wild type (Fig. 3 A),
but no change in the percent of cells in the IZ (Fig. 3 B) or SVZ/VZ (Fig. 3 C). CHL1-minus
neurons expressing pCIG2 often displayed abnormal leading processes that were slightly
branched (Fig. 2 H, arrows) or misoriented (Fig. 2 I, arrows), particularly in the lower CP.
These features in electroporated slices were in accord with the morphology of pyramidal cells
in layers V/VI in caudal cortical areas of unlabeled CHL1-minus mice in vivo (Demyanenko
et al., 2004).
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Expression of pCIG2-PAK1 AID in CHL1-minus neurons caused a striking change in
morphology, typified by wavy (Fig. 2 J, arrow) or misoriented leading processes that were
profusely branched particularly in the lower CP and IZ (Fig. 2 K,L, arrows). Higher
magnification of these cells showed two classes of approximately equal proportion: one class
had densely branched processes emanating from a single leading process (Fig. 2 M), while
another class had densely branched processes that emerged from the cell soma at multiple
points (Fig. 2N). These highly branched EGFP-labeled cells were of neuronal origin, as their
processes bore dendritic spines characteristic of wild type neurons (Fig. 2 O, P). These EGFP-
labeled cells were not radial glia or astrocytes, which do not have spines, and they did not co-
express RC2, a marker localized to radial glial processes (Fig. 2, L1). Furthermore, other studies
have demonstrated that 2–3 days after electroporation of E14.5 embryos into the lateral
ventricles, GFP-labeled cells within the CP and IZ are neurons (Yokota et al., 2007).
An antibody recognizing the activated forms of PAK1-3 was used to verify that PAK1-AID
expression inhibited PAK1-3 activity in wild type and CHL1-minus cortical slices (E14.5)
after 3 days in culture. The phospho-PAK antibody used detects endogenous activated PAK1,
PAK2, and PAK3 only when phosphorylated at Thr423, Thr402, and Thr421, respectively. In
wild type (Fig. 2 Q) and CHL1-minus neurons (Fig. 2 S) expressing pCIG2, puncate staining
of active, phospho-PAK1-3 was present in the cytoplasm of neuronal soma and processes,
including the leading process, and appeared similar in both genotypes. This pattern of staining
has also been observed in neurons in developing mouse neocortex (Causeret et al., 2009) and
in primary cultured cortical neurons from E16.5 mice (Hayashi et al., 2002,Hayashi et al.,
2007). The similar intensity of phospho-PAK staining in wild type and mutant neurons
suggested that PAK might not be a direct downstream effector of CHL1 but a component of a
parallel pathway. In pCIG2-PAK1AID–expressing wild type (Fig. 2 R) and CHL1-minus
neurons (Fig. 2 T) staining for active PAK1-3 was much reduced, indicting inactivation of
PAK1-3. Control staining without phospho-PAK antibodies was negative for all samples, as
shown in CHL1-minus neurons expressing pCIG2-PAK1AID (Fig. 2 U).
To quantitatively compare the morphological changes, the number of nodes, terminals, and
total length of processes of EGFP-labeled neurons in the upper IZ and CP were compared in
cortical slices after 3 div (Fig. 4 A–C). Electroporation of PAK1 AID in wild type cortical
neurons caused a small increase (4–6 fold, t-test; p<0.05) in the number of branch points
(nodes), terminals (ends), and total length of neuronal processes per cell, compared to wild
type embryos electroporated with pCIG2 (Fig. 4). CHL1 null mutant cells electroporated with
pCIG2 also showed a small, significant increase in the number of nodes and terminals per
neuron compared to wild type cells containing pCIG2 (2–3.6 fold), although total process
length was not different. Electroporation of PAK1 AID into CHL1 null mutants caused large
increases in the number of nodes and terminals of leading processes/apical dendrites compared
to CHL1 mutants with pCIG2 alone (6–11 fold), as well as an increase in total process length.
The increase in nodes, terminals, and process length of EGFP-labeled neurons in PAK1 AID-
expressing CHL1 null mutants was also significantly greater than in wild type cells with or
without PAK1 AID expression (Fig. 4). These results indicate that CHL1 and PAK1-3
cooperate in regulating morphological development of the leading process/apical dendrite of
embryonic cortical neurons.
Discussion
Here, we identify a novel cooperation between CHL1 and PAK1-3 in regulating the
morphology of neuronal precursors during stages of radial migration and early differentiation
in mouse embryonic cortex. Group I PAK1-3 isoforms were prominently expressed in neuronal
precursors in the IZ and CP of the developing mouse neocortex during stages corresponding
to migration and differentiation. PAK1-3 colocalized with CHL1 in the soma and processes of
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embryonic cortical neurons in the caudal region of the neocortex, where CHL1 functions in
neuronal positioning and dendritic projection (Demyanenko et al., 2004). Inactivation of
PAK1-3 kinase in wild type embryos (E14.5) induced by expressing PAK1 AID caused small
but significant increases in neuronal branching, as well as some misorientation of leading
processes. In CHL1 null mutant mice many cortical neurons have misoriented apical dendrites
and shortened leading processes, as well as neuronal positioning defects (Demyanenko et al.,
2004). Here we show that loss of CHL1 coupled with inactivation of PAK1-3 by PAK1-AID
induced profuse branching of the leading process/apical dendrite, as well as elaboration of
processes from the soma to form multipolar-like cells in the IZ and CP. This phenotype was
most likely cell autonomous in neurons, because radial glia and Cajal-Retzius cells are
unaffected by loss of CHL1 (Demyanenko et al., 2004). PAK1-3 activation did not appear to
be downstream of CHL1, as phosphorylated, activated PAK1-3 immunoreactivity appeared
similar in wild type and CHL1-minus cortical neurons. Thus CHL1 and Group I PAKs may
function independently to suppress process branching of neuronal precursors in the developing
neocortex during migration and differentiation.
A role for Group I PAKs in regulating neuronal process elaboration is supported by studies in
which premature expression of PAK3 in immature, migratory interneurons induces
inappropriate outgrowth of neurites, causing cells to arrest in the basal ganglia (Cobos et al.,
2007). Our studies are in general accord with another report in which downregulation of PAK1
by shRNA expression in wild type E14.5 mouse cortical neurons induced elaboration of
protrusions from the soma, as well as disorganization of apical extensions (Causeret et al.,
2009). However, these cells did not exhibit the densely branched morphology of neurons
lacking CHL1. In contrast to our findings, knockdown of PAK1 decreased neuronal migration
through the IZ and lower CP, when PAK1-specific shRNA was electroporated at E14.5 and
allowed to proceed in utero until P0 (Causeret et al., 2009). Although we did not observe a
statistically significant effect of PAK1 AID expression on cortical positioning of wild type
neurons after electroporation at E14.5 after 3 div in organotypic slice cultures, there was a
decreasing trend in the percent of cells in the MZ and CP and a corresponding increase in the
SVZ and VZ. This trend might have become significant at longer incubation times, which was
precluded by the limitations of our organotypic cultures. Another consideration is that PAK
inhibition by PAK1 hnRNA and PAK1 AID could have different effects, since PAK1 AID
inhibits kinase-dependent functions but not necessarily scaffolding functions. Scaffolding
functions of PAK might contribute to migration, for example by recruitment of signaling
intermediates to the plasma membrane (Sundberg-Smith et al., 2005, Higuchi et al., 2008).
Our results suggest that CHL1 and PAK1-3 function in independent, possibly compensatory
pathways to suppress neuronal branching and regulate morphological development of the
leading process/apical dendrite, since attenuation of both leads to a much greater change in
dendritic morphology than attenuation of each one separately. In the developing neocortex the
secreted protein Semaphorin3A (Sema3A) attracts apical dendrites/leading processes of
cortical neurons to the pial surface (Polleux et al., 1998), and inhibits branching of cortical
neuronal processes in vitro (Dent et al., 2004). Loss of Sema3A or its receptor Neuropilin-1
induces branching and misorientation of the leading process in developing mouse cortex,
impairing radial migration (Chen et al., 2008). CHL1 is known to bind Neuropilin-1 and
mediate Sema3A-induced neuronal responses such as growth cone collapse (Wright et al.,
2007). Thus, CHL1 may be an upstream component of the Sema3A/Neuropilin-1 signaling
pathway, which suppresses branching of the apical dendrite/leading process during migration.
In a parallel pathway, PAK1-3 might also suppress branching by maintaining integrin-
dependent adhesion of migrating neurons to radial glia, as it is a well-established integrin
signaling intermediate in various cell types (Slack-Davis et al., 2003, Guo et al., 2007). In the
developing neocortex, α3β1 integrin regulates attachment of the leading process to radial glia,
facilitating radial migration of cortical neurons (Anton et al., 1999, Sanada et al., 2004). By
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functioning in independent pathways, CHL1 and PAK1-3 may coordinately suppress neuronal
process elaboration, until the neuron attains its appropriate laminar position, detaches from
radial glial guides, and elaborates its dendritic arbor.
Abbreviations
CHL1 close homolog of L1
CP cortical plate
GFP green fluorescent protein
IZ intermediate zone
MZ marginal zone
PAK p21-activated kinase (PAK1-3) family of serine/threonine kinases
SVZ subventricular zone
VZ ventricular zone
wild type wild type
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Figure 1. PAK1-3 expression in the Developing Mouse Neocortex
(A – E), Coronal sections of wild type embryos at E14.5, E15.5, E17.5 (A,B, D), wild type
(WT) P12 mice (E), and CHL1 null mutant E15.5 embryos (C) were stained with antibody to
PAK1, which also recognizes PAK 2 and 3. Neuronal soma in layers II, V, and VI are indicated
in boxes.
(F), Control staining with nonimmune IgG in WT (E15.5) cortex.
(G, H), Staining for active PAK1-3 in E15.5 cortex from wild type and CHL1 null mutant mice
with antibody recognizing phospho-Thr423 in PAK1 or equivalent sites in PAK2-3 showed
equivalent patterns with highest levels in the IZ.
(I), Immunoblot of cortical lysates (60 µg) from E14.5, E17.5, and P12 wild type brains for
PAK1-3 with reprobing for actin as loading control.
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(J), Staining for CHL1 (red) and PAK1-3 (green) in wild type (E15.5) cortex showing
colocalization (merge) in cortical neurons located in the IZ/SVZ (arrows). Red line indicates
the IZ and SVZ boundary.
I–VI, layers of the cortex; LV, lateral ventricle; VZ, ventricular zone; SVZ, subventricular
zone; IZ, intermediate zone; CP, cortical plate; MZ, marginal zone.
Scale bars: (A–H) 100 m; (I) 10 µm.
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Figure 2. Effect of PAK1 AID Expression on Neuronal Morphology and Positioning in Wild Type
and CHL1 Null Mutant Cortex
(A), Diagram of PAK1, showing the p21-binding domain (PBD), auto-inhibitory domain
(AID), N-terminal regulatory domain (yellow), kinase domain (green), as well as sites of
phosphorylation at T212 and T423.
(B), Diagram of pCIG2 PAK1 AID plasmid containing the auto-inhibitory domain under the
chicken β-actin promoter with a CMV early-immediate enhancer. The plasmid insert is
followed by an IRES-EGFP sequence for coexpression of EGFP.
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(C,D), GFP-expressing cells after electroporation of control pCIG2 plasmid into wild type
embryos at E14.5, and culturing of slices for 3 div. (D), High magnification of wild type cortical
plate (CP) showing GFP-labeled cells with one leading process (arrows).
(E,F), pCIG2 PAK1 AID was electroporated into wild type embryos at E14.5 and cortical
slices were incubated for 3 div. (F), High magnification of wild type CP shows cells with
misoriented and/or branching processes (arrows).
(G,H,I), GFP-expressing cells after control pCIG2 plasmid was electroporated into CHL1-
minus embryos at E14.5, and cortical slices incubated for 3 div. (H), High magnification
showing cells with branched or wavy leading processes (arrows). (I), Neurons in IZ and CP
with inverted or misoriented leading processes (arrows).
(J–O) pCIG2 PAK1 AID was electroporated into CHL1-minus embryos at E14.5, and caudal
cortical slices incubated for 3 div. (J), arrow shows wavy apical dendrite in the CP. (K), arrows
show highly branched GFP-labeled cells. (L), Higher magnification of K shows details of
highly branched cells in the upper IZ and CP (arrows). (L1), Radial glial processes (red arrow)
were labeled with RC2 antibody (red) and GFP-expressing highly branched cells (green arrow)
were labeled with GFP antibodies (green) in CHL1-minus cortex (E15.5). Colocalization was
not evident in the merged image shown.
(M), High magnification of GFP-labeled cell expressing pCIG2 PAK1 AID with densely
branched processes off a single leading process/apical dendrite.
(N), High magnification of GFP-labeled cell expressing pCIG2 PAK1 AID with multiple
branched processes emerging from the soma.
(O,P), Dendritic spines (arrows) on GFP-labeled wild type and CHL1-minus neuronal
processes expressing PAK1 AID.
(Q–U) pCIG2 or pCIG2-PAK1 AID plasmids were electroporated into wild type or CHL1-
minus embryos at E14.5, and cortical slices incubated for 3 days in vitro (div), then
immunostained for activated, phospho-PAK1 (p~PAK). Localization of phospho-PAK1 (red)
in GFP-positive neurons (green) was evident as punctate labeling (yellow) in single confocal
images. Control staining with no primary antibody in (U) for pCIG2-PAK1AID plasmid in
CHL1-minus neurons.
VZ, ventricular zone; SVZ, subventricular zone; IZ, intermediate zone; CP, cortical plate; MZ,
marginal zone. Scale bars: (C,E,G,I,J,K) 50 µm; (D,F,H,L–P) 30 µm; (Q–U) 25 µm.
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Figure 3. Analysis of Neuronal Positioning in Wild Type and CHL1 Null Mutant Cortex and
Influence of PAK1 AID
Wild type or CHL1-deficient cortex (E14.5) was electroporated with pCIG2 or pCIG2 PAK1
AID plasmids, and caudal cortical slices incubated for 3 div, as shown in Fig. 2. GFP-positive
neurons (n, number of cells) were scored in multiple confocal images in bins corresponding to
the VZ/SVZ, IZ, CP/MZ. The percent of cells in each bin was calculated (A, MZ-CP; B, IZ;
C, SVZ-VZ), and group means ± SEM compared for significant differences in a pairwise
manner by the t-test (p< 0.05) as indicated by asterisks.
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Figure 4. Analysis of Neuronal Morphology in Wild Type and CHL1 Null Mutant Cortex and
Influence of PAK1 AID Expression
Wild type and CHL1 null mutant cortex were electroporated at E14.5 with control pCIG2 or
pCIG2 PAK1 AID plasmids, and caudal cortical slices incubated for 3 div. The number of
nodes (branch points) (A), terminals (ends) (B), and total length of processes (C) were
measured for each neuron (n, number of neurons) from confocal images using Neurolucida
software and means ± SEM calculated. Pairwise comparison of means was determined using
the t-test with significant differences at p<0.05, as indicated by asterisks.
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